Opinion: Abandoned by the System

Lab techs and other highly qualified employees are too often given short shrift by the biomedical research enterprise.

Written bySteve Charette, Antony Vincent, and Jean Barbeau
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, NEETALPAREKHWhen starting up a laboratory, early-career researchers usually hire a lab technician or a research assistant. These “permanent” employees—i.e. non-students—are a vital part of any lab. They are often in charge of training newcomers and are responsible for specialized research platforms. With their unique expertise and experience, they are also the memory of the lab.

Early-career researchers have to deal with a great deal of stress due to the responsibilities inherent to their jobs, such as writing grants, preparing courses, supervising their labs, and attending to teaching and administrative duties. On top of this, they need to churn out research results. Highly qualified employees (HQEs), such as experienced lab techs and research assistants, are vital to this process because they serve as a bridge between the principal investigator (PI) and the lab and enable the PI to concentrate on other tasks.

Problems for these employees arise when funding is lost or their bosses retire. This can be very stressful for HQEs, who are faced with an increasingly shaky job market. What’s worse, many Canadian universities do not consider such HQEs ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies